Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Hindustan Bio Sciences

532041
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Hindustan Bio Sciences Share price and Fundamental Analysis

View All Details
View All Details
Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991. The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates.
Company Incorporation1991
ChairmanJ.V.R. Mohan Raju
Head QuartersHyderabad
Previous NameNA

Key Metrics

Market Cap (Cr)
9.35
PE Ratio
91.2
Industry P/E
34.52
PEG Ratio
1.29
ROE
11.14%
ROCE
2.92%
ROA
2.92%
Total Debt (Cr)
2.51
Debt to Equity
2.77
Dividend Yield
0%
EPS
0.1
Book Value & P/B
0.88 x 10.39
Face Value
2
Outstanding Shares(Cr)
1.03
Current Ratio
73.31
EV to Sales
14.99

Stock Returns

1 Week-2.04%
1 Month+13.43%
6 Months-15.16%
1 Year+8.44%
3 Years+125.74%
5 Years+424.14%

CAGR

1 Year CAGR

Revenue Growth

+14.15%

Net Profit Growth

-242.37%

Operating Profit Growth

-326.54%

Dividend Growth

N/A

Stock Returns CAGR

+7.93%
no_data

No Stocks

Smart Score

2
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 12.19%

FIIs : 0.00%

DIIs : 0.00%

Public : 87.81%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Hindustan Bio Sciences Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Hindustan Bio Sciences Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991. The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates.

Previously, it was engaged in cement manufacturing and due to sluggish in the industry the company diversified its business into Bio Technology & Pharmaceuticals activities and the name of the Company was changed from Garuda Cements to Hindustan Bio-Sciences Ltd. In 2001, it diversified into software field and subsequently changed its name to Hindustan Softel Limited which presently got changed into Hindustan Bio Sciences Ltd.

The Company acquired the shares of Venkar Chemicals Ltd in 2004 and consequently upon acquisition, it became Wholly owned subsidiary of the Company with effect from 19.08.2004.

During 2006-07, Company got approval from Drugs Controller General of India (DCGI) and started marketing the nephrology product 'Recombinant Human Erythropoietin' with the brand name 'EPOVIN' from June, 2007.

The Company to its credit has world class manufacturing facilities for dry and liquid injectables, liquid/dry syrups, Eye/Ear/Nasal drops, pre-filled syringes and non sterile/sterile ointments, tablets and capsules approved by several regulatory authorities and is trusted by healthcare professionals and patients across the globe. Presently, it is now manufacturing and marketing finished dosage forms of pharmaceutical products.

Hindustan Bio Sciences Share Price

Hindustan Bio Sciences share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Hindustan Bio Sciences Market Cap

Market capitalization of Hindustan Bio Sciences indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Hindustan Bio Sciences is valued compared to its competitors.

Hindustan Bio Sciences PE Ratio

Hindustan Bio Sciences PE ratio helps investors understand what is the market value of each stock compared to Hindustan Bio Sciences 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Hindustan Bio Sciences PEG Ratio

The PEG ratio of Hindustan Bio Sciences evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Hindustan Bio Sciences ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Hindustan Bio Sciences generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Hindustan Bio Sciences ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Hindustan Bio Sciences in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Hindustan Bio Sciences Total Debt

Total debt of Hindustan Bio Sciences shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Hindustan Bio Sciences Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Hindustan Bio Sciences compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Hindustan Bio Sciences CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Hindustan Bio Sciences over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Hindustan Bio Sciences Technical Analysis

Technical analysis of Hindustan Bio Sciences helps investors get an insight into when they can enter or exit the stock. Key components of Hindustan Bio Sciences Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Hindustan Bio Sciences shares often struggle to rise above due to selling pressure.

Hindustan Bio Sciences Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Hindustan Bio Sciences ’s financial health and profitability.

Hindustan Bio Sciences Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Hindustan Bio Sciences Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Hindustan Bio Sciences Financials

The financials of Hindustan Bio Sciences provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Hindustan Bio Sciences Profit and Loss Statements

The profit and loss statement of Hindustan Bio Sciences highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Hindustan Bio Sciences .

Hindustan Bio Sciences Balance Sheet

The balance sheet presents a snapshot of Hindustan Bio Sciences ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Hindustan Bio Sciences Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App